AdvanSource Biomaterials Corp | Business Contracts

Contribution Agreement, dated February 23, 2023, by and among the Company, Nordicus, GK Partners ApS, Henrik Rouf and Life Science Power House ApS (Filed With SEC on March 1, 2023)

Indemnification Agreement dated as of October 12, 2021 between EKIMAS Corporation and Bennett J. Yankowitz (Filed With SEC on October 18, 2021)

Asset Purchase Agreement, dated November 25, 2019, by and between AdvanSource Biomaterials Corporation and Mitsubishi Chemical Performance Polymers, Inc (Filed With SEC on December 2, 2019)

Warrant to Purchase Common Stock, dated November 28, 2022, issued to David Volpe (Filed With SEC on November 30, 2022)

Warrant to Purchase Common Stock, dated November 28, 2022, issued to Bennett J. Yankowitz (Filed With SEC on November 30, 2022)

Demand Promissory Note, dated October 14, 2022, made by the Company to the Lender (Filed With SEC on October 17, 2022)

Warrant dated as of April 1, 2022 issued by EKIMAS Corporation to GK Partners AsP (Filed With SEC on April 12, 2022)

Stock Purchase Agreement dated as of October 12, 2021 between EKIMAS Corporation and Reddington Partners LLC (Filed With SEC on October 18, 2021)

Form of Voting and Support Agreement (Filed With SEC on December 2, 2019)

AdvanSource Biomaterials Corp (9)